Commission Regulation (EU) 2015/1221 of 24 July 2015 amending Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures, for the purposes of its adaptation to technical and scientific progress (Text with EEA relevance)
Date: 2015-07-24
Institutions: European Commission
Subjects: chemical product, classification, dangerous substance, labelling, marketing standard, packaging, scientific progress, technological change




L_2015197EN.01001001.xml










25.7.2015   


EN


Official Journal of the European Union


L 197/10








            COMMISSION REGULATION (EU) 2015/1221
of 24 July 2015
         
amending Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures, for the purposes of its adaptation to technical and scientific progress
(Text with EEA relevance)


THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,


Having regard to Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006 (1), and in particular Article 37(5) thereof,

Whereas:







(1)


Part 3 of Annex VI to Regulation (EC) No 1272/2008 contains two lists of harmonised classification and labelling of hazardous substances. Table 3.1 lists the harmonised classification and labelling of hazardous substances based on the criteria set out in Parts 2 to 5 of Annex I to Regulation (EC) No 1272/2008. Table 3.2 lists the harmonised classification and labelling of hazardous substances based on the criteria set out in Annex VI to Council Directive 67/548/EEC (2).












(2)


Proposals for new or updated harmonised classification and labelling of certain substances have been submitted to the European Chemicals Agency (ECHA) pursuant to Article 37 of Regulation (EC) No 1272/2008. Based on the opinions on those proposals issued by the Committee for Risk Assessment of ECHA, as well as on the comments received from the parties concerned, it is appropriate to introduce or update harmonised classification and labelling of certain substances by amending Annex VI to that Regulation.












(3)


With regard to the substance nitric acid … % (EC number: 231-714-2), new scientific data has been made available for the hazard class ‘acute toxicity’ which suggests that the classification for this hazard class as recommended in the RAC opinion, which is based on older data, might not be appropriate. Therefore, this hazard class should not be included in Annex VI to Regulation (EC) No 1272/2008 until RAC has issued an opinion on the new information, while all other classes covered by the earlier opinion should be included.












(4)


With regard to the substance phenol, dodecyl-, branched (EC number: 310-154-3), the RAC is in the process of adopting a new opinion for the specific concentration limits to be applied to the hazard class ‘toxic for reproduction’. Therefore, this hazard class should not be included in Annex VI to Regulation (EC) No 1272/2008 until that opinion is finalised.












(5)


Compliance with the new harmonised classifications should not be required immediately, as a certain period of time will be necessary to allow suppliers to adapt the labelling and packaging of substances and mixtures to the new classifications and to sell existing stocks. In addition, a certain period of time will be necessary to allow suppliers to comply with the registration obligations resulting from the new harmonised classifications for substances classified as carcinogenic, mutagenic or toxic to reproduction, categories 1A and 1B (Table 3.1) and categories 1 and 2 (Table 3.2), or as very toxic to aquatic organisms which may cause long term effects in the aquatic environment, in particular with those set out in Article 23 of Regulation (EC) No 1907/2006 of the European Parliament and of the Council (3).












(6)


In line with the transitional provisions of Regulation (EC) No 1272/2008 which allow the application of the new provisions at an earlier stage on a voluntary basis, suppliers should have the possibility of applying the new harmonised classifications and of adapting the labelling and packaging accordingly on a voluntary basis before the deadline for compliance.












(7)


The measures provided for in this Regulation are in accordance with the opinion of the Committee established under Article 133 of Regulation (EC) No 1907/2006,





HAS ADOPTED THIS REGULATION:



Article 1
Annex VI to Regulation (EC) No 1272/2008 is amended in accordance with the Annex to this Regulation.


Article 2
By way of derogation from Article 3(2), the harmonised classifications set out in Annex to this Regulation may be applied before the date referred to in Article 3(2).


Article 3

1.   This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.


2.   Article 1 shall apply in respect of substances and mixtures from 1 January 2017.





This Regulation shall be binding in its entirety and directly applicable in all Member States.
Done at Brussels, 24 July 2015.


For the Commission


The President

Jean-Claude JUNCKER
            





(1)  
            OJ L 353, 31.12.2008, p. 1.

(2)  Council Directive 67/548/EEC of 27 June 1967 on the approximation of laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances (OJ 196, 16.8.1967, p. 1).

(3)  Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC (OJ L 396, 30.12.2006, p. 1).




ANNEX
Part 3 of Annex VI to Regulation (EC) No 1272/2008 is amended as follows:






(1)


Table 3.1 is amended as follows:






(a)


the entries corresponding to index numbers 007-004-00-1, 015-003-00-2, 031-001-00-4, 050-008-00-3, 603-102-00-9, 603-197-00-7, 606-054-00-7, 607-197-00-8, 613-042-00-5, 613-057-00-7, 613-133-00-X, and 613-149-00-7 are replaced by the following corresponding entries:















Index No


International Chemical Identification


EC No


CAS No


Classification


Labelling


Specific Conc. Limits, M-factors


Notes




Hazard Class and Category Code(s)


Hazard statement Code(s)


Pictogram, Signal Word Code(s)


Hazard statement Code(s)


Suppl. Hazard statement Code(s)




007-004-00-1


nitric acid … %


231-714-2


7697-37-2


Ox. Liq. 2
Skin Corr. 1A


H272
H314


GHS03
GHS05
Dgr


H272
H314


EUH071


Skin Corr. 1A; H314: C ≥ 20 %
Skin Corr. 1B; H314: 5 % ≤ C < 20 %
Ox. Liq. 2; H272: C ≥ 99 %
Ox. Liq. 3; H272: 99 % > C ≥ 65 %


B




015-003-00-2


calcium phosphide; tricalcium diphosphide


215-142-0


1305-99-3


Water-react. 1
Acute Tox. 2
Acute Tox. 3
Acute Tox. 1
Eye Dam. 1
Aquatic Acute 1


H260
H300
H311
H330
H318
H400


GHS02
GHS06
GHS05
GHS09
Dgr


H260
H300
H311
H330
H318
H400


EUH029
EUH032


M = 100


 




031-001-00-4


gallium arsenide


215-114-8


1303-00-0


Repr. 1B
Carc. 1B
STOT RE 1


H360F
H350
H372 (respiratory and haematopoietic systems)


GHS08
Dgr


H360F
H350
H372 (respiratory and haematopoietic systems)


 


 


 




050-008-00-3


tributyltin compounds, with the exception of those specified elsewhere in this annex


—


—


Repr. 1B
Acute Tox. 3
Acute Tox. 4*
STOT RE 1
Skin Irrit. 2
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1


H360FD
H301
H312
H372**
H315
H319
H400
H410


GHS08
GHS06
GHS09
Dgr


H360FD
H301
H312
H372**
H315
H319
H410


 


*
STOT RE 1; H372: C ≥ 1 %
STOT RE 2; H373: 0,25 % ≤ C < 1 %
Skin Irrit. 2; H315:C ≥ 1 %
Eye Irrit. 2; H319:C ≥ 1 %
M = 10


A
1




603-102-00-9


1,2-epoxybutane


203-438-2


106-88-7


Flam. Liq. 2
Carc. 2
Acute Tox. 4*
Acute Tox. 4*
Acute Tox. 4*
STOT SE 3
Skin Irrit. 2
Eye Irrit. 2


H225
H351
H302
H312
H332
H335
H315
H319


GHS02
GHS08
GHS07
Dgr


H225
H351
H302
H312
H332
H335
H315
H319


 


 


 




603-197-00-7


tebuconazole (ISO); 1-(4-chlorophenyl)-4,4-dimethyl-3-(1,2,4-triazol-1-ylmethyl)pentan-3-ol


403-640-2


107534-96-3


Repr. 2
Acute Tox. 4
Aquatic Acute 1
Aquatic Chronic 1


H361d***
H302
H400
H410


GHS08
GHS07
GHS09
Wng


H361d***
H302
H410


 


M = 1
M = 10


 




606-054-00-7


isoxaflutole (ISO); 5-cyclopropyl-1,2-oxazol-4-yl α,α,α-trifluoro-2-mesyl-p-tolyl ketone


—


141112-29-0


Repr. 2
Aquatic Acute 1
Aquatic Chronic 1


H361d***
H400
H410


GHS08
GHS09
Wng


H361d***
H410


 


M = 10
M = 100


 




607-197-00-8


nonanoic acid


203-931-2


112-05-0


Skin Irrit. 2
Eye Irrit. 2
Aquatic Chronic 3


H315
H319
H412


GHS07
Wng


H315
H319
H412


 


 


 




613-042-00-5


imazalil (ISO); 1-[2-(allyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole


252-615-0


35554-44-0


Carc. 2
Acute Tox. 3
Acute Tox. 4
Eye Dam. 1
Aquatic Chronic 1


H351
H301
H332
H318
H410


GHS08
GHS06
GHS05
GHS09
Dgr


H351
H301
H332
H318
H410


 


M = 10


 




613-057-00-7


dodemorph (ISO); 4-cyclododecyl-2,6-dimethylmorpholine


216-474-9


1593-77-7


Repr. 2
STOT RE 2
Skin Corr. 1C
Skin Sens. 1A
Aquatic Acute 1
Aquatic Chronic 1


H361d
H373 (liver)
H314
H317
H400
H410


GHS08
GHS05
GHS07
GHS09
Dgr


H361d
H373 (liver)
H314
H317
H410


EUH071


M = 1
M = 1


 




613-133-00-X


etridiazole (ISO); 5-ethoxy-3-trichloromethyl- 1,2,4-thiadiazole


219-991-8


2593-15-9


Carc. 2
Acute Tox. 4
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1


H351
H302
H317
H400
H410


GHS08
GHS07
GHS09
Wng


H351
H302
H317
H410


 


M = 1
M = 1


 




613-149-00-7


pyridaben (ISO); 2-tert-butyl-5-(4-tert-butylbenzylthio)-4-chloropyridazin-3(2H)-one


405-700-3


96489-71-3


Acute Tox. 3
Acute Tox. 3
Aquatic Acute 1
Aquatic Chronic 1


H331
H301
H400
H410


GHS06
GHS09
Dgr


H331
H301
H410


 


M = 1 000 
M = 1 000 


 














(b)


the following entries are inserted in accordance with the order of the entries set out in Table 3.1:















Index No


International Chemical Identification


EC No


CAS No


Classification


Labelling


Specific Conc. Limits, M-factors


Notes




Hazard Class and Category Code(s)


Hazard statement Code(s)


Pictogram, Signal Word Code(s)


Hazard statement Code(s)


Suppl. Hazard statement Code(s)




019-003-00-3


potassium (E,E)-hexa-2,4-dienoate


246-376-1


24634-61-5


Eye Irrit. 2


H319


GSH07
Wng


H319


 


 


 




604-092-00-9


phenol, dodecyl-, branched [1];
phenol, 2-dodecyl-, branched;
phenol, 3-dodecyl-, branched;
phenol, 4-dodecyl-, branched;
phenol, (tetrapropenyl) derivatives [2]


310-154-3 [1]


121158-58-5 [1]
74499-35-7 [2]


Skin Corr. 1C
Aquatic Acute 1
Aquatic Chronic 1


H314
H400
H410


GHS05
GHS09
Dgr


H314
H410


 


M = 10
M = 10


 




606-148-00-8


carvone (ISO);
2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-one; [1]
d-carvone; (5S)-2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-one; [2]
l-carvone; (5R)-2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-one [3]


202-759-5 [1]
218-827-2 [2]
229-352-5 [3]


99-49-0 [1]
2244-16-8 [2]
6485-40-1 [3]


Skin Sens. 1


H317


GHS07
Wng


H317


 


 


 




606-149-00-3


tembotrione (ISO); 2-{2-chloro-4-(methylsulfonyl)-3-[(2,2,2-trifluoroethoxy)methyl]benzoyl}cyclohexane-1,3-dione


—


335104-84-2


Repr. 2
STOT RE 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1


H361d
H373 (eyes, kidneys, liver)
H317
H400
H410


GHS08
GHS07
GHS09
Wng


H361d
H373 (eyes, kidneys, liver)
H317
H410


 


M = 100
M = 10


 




607-707-00-9


fenoxaprop-P-ethyl (ISO); ethyl (2R)-2-{4-[(6-chloro-1,3-benzoxazol-2-yl)oxy]phenoxy}propanoate


—


71283-80-2


STOT RE 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1


H373 (kidneys)
H317
H400
H410


GHS08
GHS07
GHS09
Wng


H373 (kidneys)
H317
H410


 


M = 1
M = 1


 




607-708-00-4


octanoic acid


204-677-5


124-07-2


Skin Corr. 1C
Aquatic Chronic 3


H314
H412


GHS05
Dgr


H314
H412


 


 


 




607-709-00-X


decanoic acid


206-376-4


334-48-5


Skin Irrit. 2
Eye Irrit. 2
Aquatic Chronic 3


H315
H319
H412


GHS07
Wng


H315
H319
H412


 


 


 




607-710-00-5


1,2-benzenedicarboxylic acid, dihexyl ester, branched and linear


271-093-5


68515-50-4


Repr. 1B


H360FD


GHS08
Dgr


H360FD


 


 


 




607-711-00-0


spirotetramat (ISO); (5s,8s)-3-(2,5-dimethylphenyl)-8-methoxy-2-oxo-1-azaspiro[4,5]dec-3-en-4-yl ethyl carbonate


—


203313-25-1


Repr. 2
STOT SE 3
Eye Irrit. 2
Skin Sens. 1A
Aquatic Acute 1
Aquatic Chronic 1


H361fd
H335
H319
H317
H400
H410


GHS08
GHS07
GHS09
Wng


H361fd
H335
H319
H317
H410


 


M = 1
M = 1


 




607-712-00-6


dodemorph acetate; 4-cyclododecyl-2,6-dimethylmorpholin-4-ium acetate


250-778-2


31717-87-0


Repr. 2
STOT RE 2
Skin Corr. 1C
Skin Sens. 1A
Aquatic Chronic 1


H361d
H373 (liver)
H314
H317
H410


GHS08
GHS05
GHS07
GHS09
Dgr


H361d
H373 (liver)
H314
H317
H410


EUH071


M = 1


 




607-713-00-1


fenpyroximate (ISO); tert-butyl 4-[({(E)-[(1,3-dimethyl-5-phenoxy-1H-pyrazol-4-yl)methylene]amino}oxy)methyl]benzoate


—


134098-61-6


Acute Tox. 3
Acute Tox. 2
Skin Sens. 1B
Aquatic Acute 1
Aquatic Chronic 1


H301
H330
H317
H400
H410


GHS06 GHS09
Dgr


H301
H330
H317
H410


 


M = 100
M = 1 000 


 




607-714-00-7


triflusulfuron-methyl; methyl 2-({[4-(dimethylamino)-6-(2,2,2-trifluoroethoxy)-1,3,5-triazin-2-yl]carbamoyl}sulfamoyl)-3-methylbenzoate


—


126535-15-7


Carc. 2
Aquatic Acute 1
Aquatic Chronic 1


H351
H400
H410


GHS08
GHS09
Wng


H351
H410


 


M = 100
M = 10


 




607-715-00-2


bifenazate (ISO); isopropyl 2-(4-methoxybiphenyl-3-yl)hydrazinecarboxylate


442-820-5


149877-41-8


STOT RE 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1


H373
H317
H400
H410


GHS08
GHS07
GHS09
Wng


H373
H317
H410


 


M = 1
M = 1


 




613-319-00-0


imidazole


206-019-2


288-32-4


Repr. 1B
Acute Tox. 4
Skin Corr. 1C


H360D
H302
H314


GHS08
GHS07
GHS05
Dgr


H360D
H302
H314


 


 


 




613-320-00-6


lenacil (ISO); 3-cyclohexyl-6,7-dihydro-1H-cyclopenta[d]pyrimidine-2,4(3H,5H)-dione


218-499-0


2164-08-1


Carc. 2
Aquatic Acute 1
Aquatic Chronic 1


H351
H400
H410


GHS08
GHS09
Wng


H351
H410


 


M = 10
M = 10


 




616-213-00-2


mandipropamid (ISO); 2-(4-chlorophenyl)-N-{2-[3-methoxy-4-(prop-2-yn-1-yloxy)phenyl]ethyl}-2-(prop-2-yn-1-yloxy)acetamide


—


374726-62-2


Aquatic Acute 1
Aquatic Chronic 1


H400
H410


GHS09
Wng


H410


 


M = 1
M = 1


 




616-214-00-8


metosulam (ISO); N-(2,6-dichloro-3-methylphenyl)-5,7-dimethoxy[1,2,4]triazolo[1,5-a]pyrimidine-2-sulfonamide


—


139528-85-1


Carc. 2
STOT RE 2
Aquatic Acute 1
Aquatic Chronic 1


H351
H373 (eyes, kidneys)
H400
H410


GHS08
GHS09
Wng


H351
H373 (eyes, kidneys)
H410


 


M = 1 000 
M = 100


 




616-215-00-3


dimethenamid-P (ISO); 2-chloro-N-(2,4-dimethyl-3-thienyl)-N-[(2S)-1-methoxypropan-2-yl]acetamide


—


163515-14-8


Acute Tox. 4
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1


H302
H317
H400
H410


GHS07
GHS09
Wng


H302
H317
H410


 


M = 10
M = 10


 




616-216-00-9


flonicamid (ISO); N-(cyanomethyl)-4-(trifluoromethyl)pyridine-3-carboxamide


—


158062-67-0


Acute Tox. 4


H302


GHS07
Wng


H302


 


 


 




616-217-00-4


sulfoxaflor (ISO); [methyl(oxo){1-[6-(trifluoromethyl)-3-pyridyl]ethyl}-λ6-sulfanylidene]cyanamide


—


946578-00-3


Acute Tox. 4
Aquatic Acute 1
Aquatic Chronic 1


H302
H400
H410


GHS07
GHS09
Wng


H302
H410


 


M = 1
M = 1


 


















(2)


Table 3.2 is amended as follows:






(a)


the entries corresponding to index numbers 007-004-00-1, 015-003-00-2, 031-001-00-4, 050-008-00-3, 603-102-00-9, 603-197-00-7, 606-054-00-7, 607-197-00-8, 613-042-00-5, 613-057-00-7, 613-133-00-X, and 613-149-00-7 are replaced by the following corresponding entries:












Index No


International Chemical Identification


EC No


CAS No


Classification


Labelling


Concentration Limits


Notes




007-004-00-1


nitric acid … %


231-714-2


7697-37-2


O; R8
C; R35


O; C
R: 8-35
S: (1/2-)26-28- 36/37/39-45-63


O; R8: C ≥ 65 %
C; R35: C ≥ 20 %
C; R34: 5 % ≤ C < 20 %


B




015-003-00-2


calcium phosphide; tricalcium diphosphide


215-142-0


1305-99-3


F; R15/29
T+; R26/28
Xn; R21
R32
Xi; R38-41
N; R50


F; T+; N
R: 15/29-21-26/28-32-38-41-50
S:(1/2-)26-28-30-36/37/39-43-45-60-61


N; R50: C ≥ 0,25 %


 




031-001-00-4


gallium arsenide


215-114-8


1303-00-0


Repr. Cat. 2; R60
Carc. Cat. 2; R45
T; R48/23


T
R: 45-48/23-60
S: 45-53


 


E




050-008-00-3


tributyltin compounds, with the exception of those specified elsewhere in this annex


—


—


Repr. Cat. 2; R60-61
T; R25-48/23/25
Xn; R21
Xi; R36/38
N; R50-53


T; N
R: 21-25-36/38-48/23/25-50/53-60-61
S: 45-53-60-61


T; R25: C ≥ 2,5 %
Xn; R22: 0,25 % ≤ C < 2,5 %
Xn: R21: C ≥ 1 %
T; R48/23/25: C ≥ 1 %
Xn; R48/20/22: 0,25 % ≤ C < 1 %
Xi; R36/38: C ≥ 1 %
N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %


A
1




603-102-00-9


1,2-epoxybutane


203-438-2


106-88-7


F; R11
Carc. Cat. 3; R40
Xn; R20/21/22
Xi; R36/37/38


F; Xn
R: 11-20/21/22-36/37/38-40-
S: (2-)9-16-29-36/37-46


 


 




603-197-00-7


tebuconazole (ISO); 1-(4-chlorophenyl)-4,4-dimethyl-3-(1,2,4-triazol-1-ylmethyl)pentan-3-ol


403-640-2


107534-96-3


Repr. Cat. 3; R63
Xn; R22
N; R50-53


Xn; N
R: 22-50/53-63
S: (2-)22-36/37-60-61


N; R50-53: C ≥ 25 %
N; R51-53: 2,5 % ≤ C <25 %
R52-53: 0,25 % ≤ C < 2,5 %


 




606-054-00-7


isoxaflutole (ISO); 5-cyclopropyl-1,2-oxazol-4-yl α, α,α-trifluoro-2-mesyl-p-tolyl ketone


—


141112-29-0


Repr. Cat. 3; R63
N; R50-53


Xn; N
R: 50/53-63
S: (2-)36/37-60-61


N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %


 




607-197-00-8


nonanoic acid


203-931-2


112-05-0


Xi; R36/38
N; R51-53


Xi; N
R: 36/38-51/53
S: (2-)46-61


 


 




613-042-00-5


imazalil (ISO); 1-[2-(allyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole


252-615-0


35554-44-0


Carc. Cat. 3; R40
Xn; R20/22
Xi; R41
N; R51-53


Xn; N
R: 20/22-40-41-51/53
S: (2-)26-36/37/39-46-61


 


 




613-057-00-7


dodemorph (ISO); 4-cyclododecyl-2,6-dimethylmorpholine


216-474-9


1593-77-7


Repr. Cat. 3; R63
C; R34
R43
N; R50-53


C; N
R: 34-43-50/53-63
S: (1/2-)26-28-36/37/39-45-60-61


C; R34: C ≥ 10 %
Xi; R36/37/38: 5 % ≤ C < 10 %
N; R50-53: C ≥ 25 %
N; R51-53: 2,5 % ≤ C < 25 %
R52-53: 0,25 % ≤ C < 2,5 %


 




613-133-00-X


etridiazole (ISO); 5-ethoxy-3-trichloromethyl- 1,2,4-thiadiazole


219-991-8


2593-15-9


Carc. Cat. 3; R40
Xn; R22
R43
N; R50-53


Xn; N
R: 22-40-43-50/53
S: (2-)36/37-46-60-61


N; R50-53: C ≥ 25 %
N; R51-53: 2,5 % ≤ C < 25 %
R52-53: 0,25 % ≤ C < 2,5 %


 




613-149-00-7


pyridaben (ISO); 2-tert-butyl-5-(4-tert-butylbenzylthio)-4-chloropyridazin-3(2H)-one


405-700-3


96489-71-3


T; R23/25
N; R50-53


T; N
R: 23/25-50/53
S: (1/2-)36/37-45-60-61


N; R50-53: C ≥ 0,025 %
N; R51-53: 0,0025 % ≤ C < 0,025 %
R52-53: 0,00025 % ≤ C < 0,0025 %


 














(b)


the following entries are inserted in accordance with the order of the entries set out in Table 3.2:












Index No


International Chemical Identification


EC No


CAS No


Classification


Labelling


Concentration Limits


Notes




019-003-00-3


potassium (E,E)-hexa-2,4-dienoate


246-376-1


24634-61-5


Xi; R36


Xi
R: 36
S: (2-)25-46


 


 




604-092-00-9


phenol, dodecyl-, branched [1];
phenol, 2-dodecyl-, branched;
phenol, 3-dodecyl-, branched;
phenol, 4-dodecyl-, branched;
phenol, (tetrapropenyl) derivatives [2]


310-154-3 [1]-[2]


121158-58-5 [1]
74499-35-7 [2]


C; R34
N; R50-53


C; N
R: 34-50/53
S: (1/2-)26-36/37/39-45-61


N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %


 




606-148-00-8


carvone (ISO);
2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-one; [1]
d-carvone; (5S)-2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-one; [2]
l-carvone; (5R)-2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-one [3]


202-759-5 [1]
218-827-2 [2]
229-352-5 [3]


99-49-0 [1]
2244-16-8 [2]
6485-40-1 [3]


R43


Xi
R: 43
S: (2-)24-37


 


 




606-149-00-3


tembotrione (ISO); 2-{2-chloro-4-(methylsulfonyl)-3-[(2,2,2-trifluoroethoxy)methyl]benzoyl}cyclohexane-1,3-dione


 


335104-84-2


Repr. Cat. 3; R63
Xn; R48/22
R43
N; R50-53


Xn; N
R: 43-48/22-50/53-63
S: (2-)36/37-46-60-61


N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 %


 




607-707-00-9


fenoxaprop-P-ethyl (ISO); ethyl (2R)-2-{4-[(6-chloro-1,3-benzoxazol-2-yl)oxy]phenoxy}propanoate


—


71283-80-2


Xn; R48/22
R43
N; R50-53


Xn; N
R: 43-48/22-50/53
S: (2-)24-37-46-60-61


N; R50-53: C ≥ 25 %
N; R51-53: 2,5 % ≤ C < 25 %
R52-53: 0,25 % ≤ C < 2,5 %


 




607-708-00-4


octanoic acid


204-677-5


124-07-2


C; R34
N; R51-53


C; N
R: 34-51/53
S: (1/2-)26-36/37/39-45-61


 


 




607-709-00-X


decanoic acid


206-376-4


334-48-5


Xi; R36/38
N; R51-53


Xi; N
R: 36/38-51/53
S: (2-)25-46-61


 


 




607-710-00-5


1,2-Benzenedicarboxylic acid, dihexyl ester, branched and linear


271-093-5


68515-50-4


Repr. Cat. 2; R60-61


T
R: 60-61
S: 53-45


 


 




607-711-00-0


spirotetramat (ISO); (5s,8s)-3-(2,5-dimethylphenyl)-8-methoxy-2-oxo-1-azaspiro[4,5]dec-3-en-4-yl ethyl carbonate


—


203313-25-1


Repr. Cat. 3; R62-63
Xi; R36/37
R43
N; R50-53


Xn; N
R: 36/37-43-50/53-62-63
S: (2-)36/37-60-61


Xi; R43: C ≥ 0,1 %
N; R50-53: C ≥ 25 %
N; R51-53: 2,5 % ≤ C < 25 %
R52-53: 0,25 % ≤ C < 2,5 %


 




607-712-00-6


dodemorph acetate; 4-cyclododecyl-2,6-dimethylmorpholin-4-ium acetate


250-778-2


31717-87-0


Repr. Cat. 3; R63
C; R34
R43
N; R51-53


C; N
R: 34-43-51/53-63
S: (1/2-)26-28-36/37/39-45-61


C; R34: C ≥ 10 %
Xi: R36/37/38: 5 % ≤ C < 10 %


 




607-713-00-1


fenpyroximate (ISO); tert-butyl 4-[({(E)-[(1,3-dimethyl-5-phenoxy-1H-pyrazol-4-yl)methylene]amino}oxy)methyl]benzoate


—


134098-61-6


T+; R26
Xn; R22
R43
N; R50-53


T+; N
R: 22-26-43-50/53
S: (1/2-)28-36/37-45-60-61-63


N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 %


 




607-714-00-7


triflusulfuron-methyl; methyl 2-({[4-(dimethylamino)-6-(2,2,2-trifluoroethoxy)-1,3,5-triazin-2-yl]carbamoyl}sulfamoyl)-3-methylbenzoate


—


126535-15-7


Carc. Cat. 3; R40
N; R50-53


Xn; N
R: 40-50/53
S: (2-)36/37-60-61


N; R50-53: C ≥ 0,25 %
N; R51-53: 0,025 % ≤ C < 0,25 %
R52-53: 0,0025 % ≤ C < 0,025 %


 




607-715-00-2


bifenazate (ISO); isopropyl 2-(4-methoxybiphenyl-3-yl)hydrazinecarboxylate


442-820-5


149877-41-8


R43
N; R50-53


Xi; N
R: 43-50/53
S: (2-)24-37-60-61


N; R50-53: C ≥ 25 %
N; R51-53: 2,5 % ≤ C < 25 %
R52-53: 0,25 % ≤ C < 2,5 %


 




613-319-00-0


imidazole


206-019-2


288-32-4


Repr. Cat 2; R61
Xn; R22
C; R34


T; C
R: 22-34-61
S: 53-45


 


 




613-320-00-6


lenacil (ISO); 3-cyclohexyl-6,7-dihydro-1H-cyclopenta[d]pyrimidine-2,4(3H,5H)-dione


218-499-0


2164-08-1


Carc. Cat. 3; R40
N; R50-53


Xn; N
R: 40-50/53
S: (2-)36/37-60-61


N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %


 




616-213-00-2


mandipropamid (ISO); 2-(4-chlorophenyl)-N-{2-[3-methoxy-4-(prop-2-yn-1-yloxy)phenyl]ethyl}-2-(prop-2-yn-1-yloxy)acetamide


—


374726-62-2


N; R50-53


N
R: 50/53
S: 60-61


N; R50-53: C ≥ 25 %
N; R51-53: 2,5 % ≤ C <25 %
R52-53: 0,25 % ≤ C < 2,5 %


 




616-214-00-8


metosulam (ISO); N-(2,6-dichloro-3-methylphenyl)-5,7-dimethoxy[1,2,4]triazolo[1,5-a]pyrimidine-2-sulfonamide


—


139528-85-1


Carc. Cat. 3; R40
Xn; R48/22
N; R50-53


Xn; N
R: 40-48/22-50/53
S: (2-)36/37-46-60-61


N; R50-53: C ≥ 0,025 %
N; R51-53: 0,0025 % ≤ C < 0,025 %
R52/53: 0,00025 % ≤ C < 0,0025 %


 




616-215-00-3


dimethenamid-P (ISO); 2-chloro-N-(2,4-dimethyl-3-thienyl)-N-[(2S)-1-methoxypropan-2-yl]acetamide


—


163515-14-8


Xn; R22
R43
N; R50-53


Xn; N
R: 22-43-50/53
S: (2-)24-37-60-61


N; R50-53: C ≥ 2,5 %
N; R51-53: 0,25 % ≤ C < 2,5 %
R52-53: 0,025 % ≤ C < 0,25 %


 




616-216-00-9


flonicamid (ISO); N-(cyanomethyl)-4-(trifluoromethyl)pyridine-3-carboxamide


—


158062-67-0


Xn; R22


Xn
R: 22
S: (2-)46


 


 




616-217-00-4


sulfoxaflor (ISO); [methyl(oxo){1-[6-(trifluoromethyl)-3-pyridyl]ethyl}-λ6-sulfanylidene]cyanamide


—


946578-00-3


Xn; R22
N; R50-53


Xn; N
R: 22-50/53
S: (2-)60-61


N; R50-53: C ≥ 25 %
N; R51-53: 2,5 % ≤ C < 25 %
R52-53: 0,25 % ≤ C < 2,5 %